Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee Jun 22, 2026 Life Science
AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths Jun 19, 2026 Life Science, Technology
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough Jun 11, 2026 Life Science
Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion Jun 8, 2026 Life Science
RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy? Jun 5, 2026 Life Science
Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities Jun 4, 2026 Life Science
Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge Jun 3, 2026 Life Science
5 Institutional-Approved High-Dividend Pharmaceutical Stocks for Passive Income Investors May 29, 2026 Life Science
Beyond Lilly and Novo Nordisk: Two Under-the-Radar Picks in the Obesity Drug Market May 26, 2026 Life Science
